US Bancorp DE cut its position in shares of Stericycle, Inc. (NASDAQ:SRCL – Free Report) by 2.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,136 shares of the business services provider’s stock after selling 862 shares during the quarter. US Bancorp DE’s holdings in Stericycle were worth $1,444,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the company. Corient Private Wealth LLC lifted its stake in Stericycle by 52.8% during the fourth quarter. Corient Private Wealth LLC now owns 10,397 shares of the business services provider’s stock worth $515,000 after purchasing an additional 3,591 shares during the last quarter. Sachetta LLC bought a new stake in Stericycle in the fourth quarter valued at $100,000. Robeco Institutional Asset Management B.V. bought a new stake in Stericycle in the fourth quarter valued at $156,000. First Eagle Investment Management LLC lifted its stake in Stericycle by 9.5% in the fourth quarter. First Eagle Investment Management LLC now owns 230,975 shares of the business services provider’s stock valued at $11,447,000 after buying an additional 20,101 shares during the last quarter. Finally, Heartland Advisors Inc. lifted its stake in Stericycle by 55.5% in the fourth quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock valued at $29,733,000 after buying an additional 208,256 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research firms have issued reports on SRCL. Royal Bank of Canada reiterated an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a research note on Thursday, March 7th. Truist Financial cut their target price on Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a research note on Monday, April 29th. Wells Fargo & Company raised their target price on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Finally, StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Stericycle has an average rating of “Hold” and a consensus price target of $59.40.
View Our Latest Research Report on SRCL
Stericycle Stock Up 4.5 %
Shares of NASDAQ SRCL opened at $51.54 on Monday. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The firm’s 50-day simple moving average is $48.84 and its 200 day simple moving average is $49.19. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11.
Stericycle (NASDAQ:SRCL – Get Free Report) last issued its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same period in the previous year, the business earned $0.49 earnings per share. The company’s revenue was down 2.8% on a year-over-year basis. On average, equities research analysts predict that Stericycle, Inc. will post 2.32 EPS for the current year.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Recommended Stories
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL – Free Report).
Receive News & Ratings for Stericycle Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Stericycle and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
